4//SEC Filing
Aerpio Pharmaceuticals, Inc. 4
Accession 0000899243-17-008151
$WHWKCIK 0001422142operating
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:37 PM ET
Size
5.9 KB
Accession
0000899243-17-008151
Insider Transaction Report
Form 4
WEISS PAUL M
Director
Transactions
- Purchase
Common Stock
2017-03-15$5.00/sh+272,302$1,361,510→ 1,576,167 total(indirect: See Footnotes)
Footnotes (2)
- [F1]The shares are held by Venture Investors Early Stage Fund IV Limited Partnership, a Delaware limited partnership. Its general partner, VIESF IV GP LLC, has sole voting and investment control over the shares owned by Venture Investors Early State Fund IV Limited Partnership. The members of VIESF IV GP LLC, John Neis, Paul M. Weiss, Scott Button, George Arida, James R. Adox, Loren G. Peterson and Venture Investors Southwest LLC (of which Roger H. Ganser is the sole member), have sole voting and investment power for VIESF IV GP LLC with respect to its voting power in its capacity as General Partner for the shares held by Venture Investors Early Stage Fund IV Limited Partnership.
- [F2](Continued from footnote 1) None of the members of VIESF IV GP LLC has individual voting or investment power with respect to the shares and each disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein Venture Investors LLC is the fund manager for Venture Investors Early Stage Fund IV Limited Partnership.
Documents
Issuer
Aerpio Pharmaceuticals, Inc.
CIK 0001422142
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001422142
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 8:37 PM ET
- Size
- 5.9 KB